China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
Conditions
Hypertension · MTHFR 677 CC or CT Genotype · Elevated Plasma Homocysteine (Hcy≥10µmol/L) · Insufficient Plasma Folate Levels (<12ng/mL)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China
Contact: Principal Investigator (Hongju Wang, MD)Bozhou, Bozhou, Anhui, China
Contact: Study coordinator (Rongyan Jiang, MD)Contact: Principal Investigator (Rongyan Jiang, MD)Chizhou People's Hospital, Chizhou, Anhui, China
Contact: Study coordinator (Xiaodong Xu, MD)Contact: Principal Investigator (Xiaodong Xu, MD)Taihe County People's Hospital, Fuyang, Anhui, China
Contact: Study coordinator (Shuguang Zhao, MD)Contact: Principal Investigator (Shuguang Zhao, MD)Contact: Principal Investigator (Yongjun Zhai, MD)Peking University First Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Yong Huo, MD)Contact: Principal Investigator (Yong Huo, MD)Yangjiang People's Hospital, Yangjiang, Guangdong, China
Contact: Study coordinator (Jiaman Ou, MD)Contact: Principal Investigator (Jiaman Ou, MD)The Affiliated Hospital Of Guizhou Medical University, Guiyang, Guizhou, China
Contact: Study coordinator (Fang Wei, MD)Contact: Principal Investigator (Wei Li, MD)Fang Wei, MD (Sub-investigator)The First Affiliated Hospital of Hunan University of Medicine, Huaihua, Hunan, China
Contact: Study coordinator (Bifeng Tan)Contact: Principal Investigator (Bifeng Tan, MD)Loudi Central Hospital, Loudi, Hunan, China
Contact: Study coordinator (Weimin Hu, MD)Contact: Principal Investigator (Weimin Hu, MD)Lianyungang Oriental Hospital, Lianyungang, Jiangsu, China
Contact: Principal Investigator (Huanxian Chang, MD)The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China
Contact: Study coordinator (Hui Shi, MD)Contact: Principal Investigator (Hui Shi, MD)The Second People's Hospital of Lianyungang, Lianyungang, Jiangsu, China
Contact: Study coordinator (Liming Sun, MD)Contact: Principal Investigator (Liming Sun, MD)Yancheng First People's Hospital, Yancheng, Jiangsu, China
Contact: Study coordinator (Qilong Zuo)Contact: Principal Investigator (Qilong Zuo, MD)The First Affiliated Hospital of Gannan Medical University,, Ganzhou, Jiangxi, China
Contact: Study coordinator (Xiaofeng Zou, MD)Contact: Principal Investigator (Xiaofeng Zou, MD)Yiming Zhong, MD (Sub-investigator)Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Contact: Study coordinator (Xiaoshu Cheng, MD)Contact: Principal Investigator (Xiaoshu Cheng, MD)Weinan Central Hospital, Weinan, Shaanxi, China
Contact: Study coordinator (Junnong Li, MD)Contact: Principal Investigator (Junnong Li, MD)Tengzhou Central People's Hospital, Zaozhuang, Shandong, China
Contact: Principal Investigator (Yong Li, MD)Chengdu Fifth People's Hospital, Chengdu, Sichuan, China
Contact: Study coordinator (Lihua Zhou, MD)Contact: Principal Investigator (Lihua Zhou, MD)Deyang People's Hospital, Deyang, Sichuan, China
Contact: Study coordinator (Xiaojian Deng, MD)Contact: Principal Investigator (Xiaojian Deng, MD)The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
Contact: Study coordinator (Juyi Wan, MD)Contact: Principal Investigator (Juyi Wan, MD)
Study leads
Yong Huo, MD, PhD
Principal Investigator
Peking University First Hospital